Mahadevia Ankit
Known title: CEO and PresidentCIK: 0001720974
Associated companies
Transaction History
| SPRO | ▼ Sell | Open Market | 6,572 | $13K | 8/28/2025 | View on chart |
| SPRO | ▲ Buy | Grant | 20,000 | $0 | 6/12/2025 | View on chart |
| SPRO | ▼ Sell | Open Market | 13,959 | $11K | 2/5/2025 | View on chart |
| SPRO | ▼ Sell | Open Market | 55,260 | $43K | 2/5/2025 | View on chart |
| SPRO | ▼ Sell | Open Market | 5,912 | $8K | 8/27/2024 | View on chart |
| SPRO | ▲ Buy | Grant | 20,000 | $0 | 5/29/2024 | View on chart |
| SPRO | ▼ Sell | Open Market | 63,795 | $87K | 2/2/2024 | View on chart |
| SPRO | ▲ Buy | Grant | 20,000 | $0 | 10/5/2023 | View on chart |
| SPRO | ▼ Sell | Open Market | 9,040 | $11K | 8/28/2023 | View on chart |
| SPRO | ▼ Sell | Open Market | 12,286 | $22K | 2/3/2023 | View on chart |
| SPRO | ▲ Buy | Grant | 531,914 | $0 | 2/1/2023 | View on chart |
| SPRO | ▲ Buy | Grant | 134,168 | $0 | 2/1/2022 | View on chart |
| SPRO | ▲ Buy | Option Exercise | 8,000 | $47K | 12/27/2021 | View on chart |
| SPRO | ▼ Sell | Open Market | 8,000 | $117K | 12/27/2021 | View on chart |
| SPRO | ▲ Buy | Grant | 78,219 | $0 | 8/26/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
SPRO among stocks that gapped in Tuesday's session
Spero Therapeutics was listed as a gapping stock on Tuesday, meaning its price opened significantly different from the previous close. Such gaps often reflect a quick shift in market sentiment. The move occurs while the stock is near its $1.19 support level and has a neutral RSI around 49.
SPRO among stocks that gapped in Tuesday's session. Spero Therapeutics was listed as a gapping stock on Tuesday, meaning its price opened significantly different from the previous close. Such gaps often reflect a quick shift in market sentiment. The move occurs while the stock is near its $1.19 support level and has a neutral RSI around 49.